VersionV4.0 ✓ Published
Effective date2026-09-30
Approved byProf. Giorgi Pkhakadze, MD, MPH, PhD — President, Accréditation Sans Frontières
Applies toAll ASF standards development, revision, and withdrawal activities
Related documentsASF-GOV-002 Standards Committee Terms of Reference · ASF-GOV-003 Impartiality Policy · ASF-EV-001–004 Evidence Documents
SupersedesASF-GOV-001 V2.0 (2026-09-30)
Next reviewSeptember 2031, or earlier on trigger (see §11)
Version History
| Version | Date | Nature of change | Approved by |
|---|---|---|---|
| V0.1 | 2024-11-10 | Initial outline — internal working draft | — |
| V1.0 | 2025-01-20 | First full draft published for Standards Committee review | Standards Development Committee |
| V2.0 | 2025-06-15 | Revised following pilot survey feedback; 9-stage lifecycle added; criterion classification table expanded | Prof. G. Pkhakadze, ASF President |
| V3.0 | 2026-03-08 | Full evidence annotation added; ISQua EEA alignment section; references expanded to 20 | Standards Development Committee |
| V4.0 | 2026-09-30 | Final pre-submission revision; approved for ISQua EEA application package | Prof. G. Pkhakadze, ASF President |
1. Purpose
1.1This document establishes the methodology by which Accréditation Sans Frontières (ASF) develops, consults upon, approves, publishes, monitors, revises, and, where necessary, withdraws healthcare accreditation standards. The methodology is designed to ensure that all ASF standards are evidence-informed, stakeholder-tested, independently reviewed, transparently governed, and subject to continuous improvement.
1.2This methodology applies to: (a) development of new accreditation standards for any healthcare facility type; (b) major revision of existing standards (defined in §9); (c) minor revision and editorial maintenance; and (d) suspension or withdrawal of standards no longer in use.
1.3This methodology is aligned with the requirements of the ISQua International Accreditation Programme (IAP) — External Evaluation Association (EEA) Principles for Standards, 6th Edition, and in particular with Principles 1 (Evidence), 2 (Stakeholder Engagement), 3 (Transparency), and 5 (Review). It is read alongside the ASF ISQua EEA Crosswalk (ASF-EV-004).
2. Scope
This methodology governs all ASF healthcare accreditation standards currently in development or active use, including the Hospital, Ambulatory Clinic, Long-Term Care, Primary Health Clinic, and Fitness and Wellness standards. It does not cover assessment tools or surveyor training materials (governed by ASF-OPS-002 and ASF-OPS-009 respectively).
3. Governance and Responsibilities
3.1Overall accountability for ASF standards development rests with the ASF Standards Development Committee (SDC), which operates under formally approved Terms of Reference (ASF-GOV-002).
| Role | Responsibilities in standards development |
|---|---|
| ASF President | Ultimate approval authority for all ASF standards; appoints SDC members; approves this methodology. |
| Standards Development Committee (SDC) | Strategic oversight of the standards portfolio; review and approval of all draft and final standards; governance of the consultation process; conflict-of-interest oversight; annual review of the forward review schedule. |
| Technical Drafting Lead | Leads evidence review and initial drafting; manages technical revision; coordinates expert and stakeholder input; maintains ASF-EV-001. |
| Stakeholder Coordination | Identifies and engages stakeholder groups; facilitates the formal consultation process; maintains the comment matrix; prepares ASF-EV-002. |
| Independent Expert Reviewers | External experts engaged on an ad hoc basis to review draft standards for clinical accuracy, measurability, and feasibility. Not SDC members; declare all conflicts of interest. |
| Document Control | Version control of all controlled documents; archiving of superseded versions; publication on france-asf.fr. |
3.3All persons involved in standards development are required to declare any conflict of interest in accordance with ASF-GOV-003. Any person with a declared conflict is excluded from decisions on the relevant standards or clauses.
4. Standards Development Lifecycle
4.1ASF applies a defined nine-stage lifecycle to all standards development activities. Each stage is documented and retained as controlled information to ensure a full audit trail from initial concept to published standard:
- 1. Stage 1 — Needs Identification and Scoping
- 2. Stage 2 — Evidence and Benchmark Review
- 3. Stage 3 — Draft Development
- 4. Stage 4 — Stakeholder Consultation
- 5. Stage 5 — Technical and Independent Expert Review
- 6. Stage 6 — Pilot Testing or Field Validation
- 7. Stage 7 — Formal Approval and Publication
- 8. Stage 8 — Post-Implementation Monitoring
- 9. Stage 9 — Scheduled Periodic Review
5. Evidence-Informed Approach (Stages 1–2)
5.1 Needs Identification and Scoping
5.1.1The first stage is a formal needs assessment leading to a documented Scoping Brief approved by the SDC, defining: the healthcare facility type and population; the regulatory and policy context; the patient safety rationale; an assessment of existing international standards; the relationship to existing ASF standards; and the proposed timeline.
5.2 Evidence and Benchmark Review
5.2.1ASF draws on six source categories: (a) international accreditation standards (ISQua member bodies, JCI, Accreditation Canada, ACHS); (b) peer-reviewed scientific and clinical literature (PubMed/MEDLINE, Cochrane Library, WHO institutional repository); (c) WHO normative guidance; (d) ISQua guidance documents, including the EEA Principles 6th Edition; (e) applicable regulatory requirements; and (f) documented expert consensus where peer-reviewed evidence is limited, flagged for prioritised future review.
5.2.2The evidence review produces an updated Standards Evidence Bibliography (ASF-EV-001) recording, for each standards domain: the principal evidence sources; quality of evidence; and any evidence gaps.
6. Draft Development (Stage 3)
6.1Draft standards follow ASF’s document architecture: numbered chapters; numbered criteria using the verb “shall”; criteria classified into four tiers; guidance notes presented separately from normative requirements; and a cross-reference table linking each criterion to its principal evidence source in ASF-EV-001.
6.2ASF criteria classification system:
| Tier | Classification | Definition |
|---|---|---|
| Critical | Class 1 — CRITICAL | Life-safety requirements whose absence creates an immediate risk to patient or staff life. Non-compliance is a barrier to accreditation. |
| Essential | Class 2 — ESSENTIAL | Core quality requirements directly linked to patient safety or clinical effectiveness. Majority compliance required for accreditation. |
| Significant | Class 3 — SIGNIFICANT | Important quality improvement requirements. Performance is scored and contributes to the accreditation decision. |
| Developmental | Class 4 — DEVELOPMENTAL | Good practice requirements reflecting the highest performance tier, distinguishing organisations of excellence. |
7. Stakeholder Consultation (Stage 4)
7.1Stakeholder consultation is mandatory in every new standards development cycle and every major revision. ASF engages: (a) healthcare facility managers and quality officers; (b) clinical professionals; (c) patient and family representatives; (d) healthcare regulatory bodies; (e) academic and research experts; (f) ASF surveyors; and (g) peer accreditation bodies.
7.3The formal consultation period is open for a minimum of 28 calendar days.
7.5All consultation responses are recorded in a Comment Matrix capturing: the stakeholder category; the criterion number; the comment text; ASF’s decision (accepted / accepted with modification / rejected); and the rationale. The matrix is summarised in the Stakeholder Consultation Summary (ASF-EV-002), published on france-asf.fr.
8. Expert Review and Pilot Testing (Stages 5–6)
8.1.1Following consultation, the revised draft is submitted for independent expert review by at least one expert not involved in drafting and with no conflict of interest, evaluating: clinical accuracy; clarity and measurability; feasibility; completeness; consistency; and alignment with international standards.
8.2.1Where practicable, ASF conducts a structured pilot or field validation exercise involving a minimum of three participating facilities selected to represent the range of types, sizes, and resource settings. Findings are published in ASF-EV-003.
9. Approval, Version Control, and Publication (Stage 7)
9.1Final SDC submission requires: the final draft; summary of changes; updated ASF-EV-001; the completed Comment Matrix and ASF-EV-002; expert review findings; pilot outcomes (ASF-EV-003); and a statement of alignment with ISQua EEA Principles cross-referenced to ASF-EV-004.
9.4Revision types: Major revision — any change affecting intent, scope, number, or measurable content of criteria; increments from V1.x to V2.0; requires full lifecycle review. Minor revision — editorial corrections and clarifications without change to requirement; approved by SDC Chair; increments as V1.1, V1.2.
10. Post-Implementation Monitoring (Stage 8)
Following publication, ASF actively monitors: survey findings data (score distributions by criterion); structured surveyor debrief; accredited organisation feedback; incident and complaint data from the risk register (ASF-QMS-003); and external signals including new WHO guidance and updates to international accreditation standards. Findings are reviewed by the SDC at least annually.
11. Scheduled Periodic Review (Stage 9)
11.1All ASF accreditation standards are reviewed at intervals not exceeding five years. A review is initiated earlier if triggered by: significant regulatory change; a new edition of a major international reference standard; new WHO guidance; systematic post-implementation issues; an SDC formal request; or a material gap identified in the annual ISQua EEA crosswalk review.
11.3This Standards Development Methodology is itself reviewed on the same five-year cycle. Next scheduled review: September 2031.
12. Document Control and Transparency
All controlled documents carry a unique code, version number, effective date, and approval signature. Superseded versions are archived and retained for a minimum of ten years. All published ASF governance documents and accreditation standards are accessible without charge on france-asf.fr. ASF accreditation standards are the intellectual property of Accréditation Sans Frontières; use by any external assessment organisation requires a formal written agreement.
13. References
| [1] | ISQua IAP. Principles for Standards. 6th Ed. ISQua EEA, Dublin, 2023. |
| [2] | Shaw CD et al. Profiling health-care accreditation organisations: an international survey. Int J Qual Health Care. 2013;25(3):222–231. doi:10.1093/intqhc/mzt008 |
| [3] | Greenfield D, Pawsey M, Braithwaite J. What motivates professionals to engage in the accreditation of healthcare organisations? Int J Qual Health Care. 2011;23(1):8–14. |
| [4] | Brubakk K et al. A systematic review of hospital accreditation: the challenges of measuring complex intervention effects. BMC Health Serv Res. 2015;15:280. |
| [5] | Joint Commission International. JCI Accreditation Standards for Hospitals. 7th Ed. JCI, Oak Brook, 2020. |
| [6] | Accreditation Canada. Qmentum Accreditation Program. Ottawa, 2022. |
| [7] | ACHS. EQuIP National Standards. 6th Ed. Sydney, 2018. |
| [8] | WHO. Standards for Improving Quality of Maternal and Newborn Care in Health Facilities. Geneva, 2016. |
| [9] | WHO. Patient Safety Curriculum Guide: Multi-professional Edition. Geneva, 2011. |
| [10] | WHO. Guidelines on Hand Hygiene in Health Care. Geneva, 2009. |
| [11] | WHO. Safe Surgery Saves Lives: The Second Global Patient Safety Challenge. Geneva, 2009. |
| [12] | Greenfield D, Braithwaite J. Health sector accreditation research: a systematic review. Int J Qual Health Care. 2008;20(3):172–183. |
| [13] | Braithwaite J et al. Comparison of health service accreditation programs in LMICs with higher income countries. Int J Qual Health Care. 2012;24(6):568–577. |
| [14] | ISO 9001:2015 — Quality Management Systems: Requirements. ISO, Geneva, 2015. |
| [15] | ISO 15189:2022 — Medical Laboratories: Requirements for Quality and Competence. ISO, Geneva, 2022. |
| [16] | HQACI. Standards Development Methodology. ISQua EEA Accredited, 2026. |
| [17] | Flodgren G et al. External inspection of compliance with standards for improved healthcare outcomes. Cochrane Database Syst Rev. 2016;12:CD008992. |
| [18] | EU Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare. OJ L 88/45, 2011. |
| [19] | Pomey MP et al. Accreditation: a tool for organisational change in hospitals? Int J Health Care Qual Assur. 2004;17(3):113–124. |
| [20] | Pkhakadze G. Healthcare accreditation and quality improvement: national and international perspectives. Georgian National Conference on Healthcare Quality, Tbilisi, 2019. |
Document code: ASF-GOV-001 · Version: V3.0 · Effective: 2026-09-30 · Next review: September 2031 ·
All governance documents
Download the approved document
ASF-GOV-001 — Standards Development Methodology · Version V4.0